Mr. Baker joined the Company in 2005 as Senior Vice President & General Counsel and Secretary. In 2008, he was appointed Executive Vice President – Corporate, in 2009 became President, and has been CEO since March 2011. From 2003 to 2005, Mr. Baker was Chief Business Officer, Secretary and a director of New York Trans Harbor LLC, a privately-held ferry operation in New York City. From 1997 to 2001, he was Executive Vice President, Chief Legal Officer and Secretary of Continental Grain Company, a privately-held international agri-business and financial concern. Prior thereto, he was a partner and Co-Chairman of the Capital Markets Group of the New York law firm Dewey Ballantine. Mr. Baker has an A.B. degree from Columbia College and a J.D. from the Columbia University School of Law.
Mark R. Baker
Chairman of the board
Certified Clinical Research Professional (CCRP) with experience in clinical research management at Memorial Sloan Kettering Cancer Center, USA. Participated in the successful execution of 510K approval of Veridex Cell Search for detection of CTC in metastatic prostate cancer. Successfully defended PhD thesis in imaging biomarker development and validation in metastatic Prostate Cancer at Lund University, Sweden.